4,869
Views
0
CrossRef citations to date
0
Altmetric
Review

Omics biomarkers and an approach for their practical implementation to delineate health status for personalized nutrition strategies

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & show all

References

  • Abadi, A., A. Alyass, S. Robiou Du Pont, B. Bolker, P. Singh, V. Mohan, R. Diaz, J. C. Engert, S. Yusuf, H. C. Gerstein, et al. 2017. Penetrance of polygenic obesity susceptibility loci across the body mass index distribution. American Journal of Human Genetics 101 (6):925–38. doi: 10.1016/j.ajhg.2017.10.007.
  • Abdul Ghani, Z. D. F., A. H. Ab Rashid, K. Shaari, and Z. Chik. 2019. Urine NMR metabolomic study on biochemical activities to investigate the effect of P. betle extract on obese rats. Applied Biochemistry and Biotechnology 189 (2):690–708. doi: 10.1007/s12010-019-03042-w.
  • Abu Bakar, M. H., M. R. Sarmidi, K. K. Cheng, A. Ali Khan, C. Lee Suan, H. Zaman Huri, and H. Yaakob. 2015. Metabolomics – The complementary field in systems biology: A review on obesity and type 2 diabetes. Molecular bioSystems 11 (7):1742–74. doi: 10.1039/c5mb00158g.
  • Acar, E., G. Gürdeniz, B. Khakimov, F. Savorani, S. K. Korndal, T. M. Larsen, S. B. Engelsen, A. Astrup, and L. O. Dragsted. 2019. Biomarkers of individual foods, and separation of diets using untargeted LC-MS-based plasma metabolomics in a randomized controlled trial. Molecular Nutrition & Food Research 63 (1):e1800215. doi: 10.1002/mnfr.201800215.
  • Afshin, A., P. J. Sur, K. A. Fay, L. Cornaby, G. Ferrara, J. S. Salama, E. C. Mullany, K. Hassen Abate, C. Abbafati, Z. Abebe, et al. 2019. Health effects of dietary risks in 195 countries, 1990–2017: A systematic analysis for the global burden of disease study 2017. The Lancet 393 (10184):1958–72. Elsevier:1958–1972. doi: 10.1016/S0140-6736(19)30041-8.
  • Aldubayan, M. A., K. Pigsborg, S. M. Gormsen, F. Serra, M. Palou, P. Mena, M. Wetzels, A. Calleja, A. Caimari, J. Del Bas, et al. 2022. Empowering consumers to PREVENT Diet-related diseases through OMICS sciences (PREVENTOMICS): Protocol for a parallel double-blinded randomised intervention trial to investigate biomarker-based nutrition plans for weight loss. BMJ Open 12 (3):e051285. doi: 10.1136/BMJOPEN-2021-051285.
  • Aleksandrova, K., L. Koelman, and C. E. Rodrigues. 2021. Dietary patterns and biomarkers of oxidative stress and inflammation: A systematic review of observational and intervention studies. Redox Biology 42 (June):101869. doi: 10.1016/j.redox.2021.101869.
  • Araújo, R., L. F. N. Bento, T. A. H. Fonseca, C. P. Von Rekowski, B. R. da Cunha, and C. R. C. Calado. 2022. Infection biomarkers based on metabolomics. Metabolites 12 (2):92. doi: 10.3390/metabo12020092.
  • Araujo, T. R., J. A. da Silva, J. F. Vettorazzi, I. N. Freitas, C. Lubaczeuski, E. A. Magalhaes, J. N. Silva, E. S. Ribeiro, A. C. Boschero, E. M. Carneiro, et al. 2019. Glucose intolerance in monosodium glutamate obesity is linked to hyperglucagonemia and insulin resistance in alpha cells. Journal of Cellular Physiology 234 (5):7019–31. doi: 10.1002/jcp.27455.
  • Augustin, K., A. Khabbush, S. Williams, S. Eaton, M. Orford, J. H. Cross, S. J. Heales, M. C. Walker, and R. S. Williams. 2018. Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. The Lancet Neurology 17 (1):84–93. doi: 10.1016/S1474-4422(17)30408-8.
  • Aulchenko, Y. S., S. Ripatti, I. Lindqvist, D. Boomsma, I. M. Heid, P. P. Pramstaller, B. W. J. H. Penninx, A. C. J. W. Janssens, J. F. Wilson, T. Spector, et al. 2009. Loci influencing lipid levels and coronary heart disease risk in 16 European Population Cohorts. Nature Genetics 41 (1):47–55. doi: 10.1038/ng.269.
  • Bantscheff, M., S. Lemeer, M. M. Savitski, and B. Kuster. 2012. Quantitative mass spectrometry in proteomics: Critical review update from 2007 to the present. Analytical and Bioanalytical Chemistry 404 (4):939–65. doi: 10.1007/s00216-012-6203-4.
  • Barabási, A.-L., G. Menichetti, and J. Loscalzo. 2019. The unmapped chemical complexity of our diet. Nature Food 1 (1):33–7. doi: 10.1038/s43016-019-0005-1.
  • Barragan, M., V. Luna, J. M. Vargas-Morales, C. Aradillas-Garcia, and M. Teran-Garcia. 2019. Uric acid: An overlooked, inexpensive biomarker of metabolic syndrome (P10-068-19). Current Developments in Nutrition 3 (Supplement_1):nzz034.P10-068-19. doi: 10.1093/cdn/nzz034.P10-068-19.
  • Beam, A., E. Clinger, and L. Hao. 2021. Effect of diet and dietary components on the composition of the gut microbiota. Nutrients 13 (8):2795. doi: 10.3390/nu13082795.
  • Beger, R. D., S. Bhattacharyya, P. S. Gill, and L. P. James. 2018. Acylcarnitines as translational biomarkers of mitochondrial dysfunction. Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants 1–2 (Cpt 2):383–93. doi: 10.1002/9781119329725.ch24.
  • Beger, R. D., W. B. Dunn, A. Bandukwala, B. Bethan, D. Broadhurst, C. B. Clish, S. Dasari, L. Derr, A. Evans, S. Fischer, et al. 2019. Towards quality assurance and quality control in untargeted metabolomics studies. Metabolomics: Official Journal of the Metabolomic Society 15 (1):4. doi: 10.1007/s11306-018-1460-7.
  • Bekebrede, A. F., T. van Deuren, W. J. J. Gerrits, J. Keijer, and V. C. J. de Boer. 2021. Butyrate alters pyruvate flux and induces lipid accumulation in cultured colonocytes. International Journal of Molecular Sciences 22 (20):10937. doi: 10.3390/ijms222010937.
  • Bene, J., A. Szabo, K. Komlosi, and B. Melegh. 2020. Mass spectrometric analysis of l-carnitine and its esters: Potential biomarkers of disturbances in carnitine homeostasis. Current Molecular Medicine 20 (5):336–54. doi: 10.2174/1566524019666191113120828.
  • Berhane, F., A. Fite, N. Daboul, W. Al-Janabi, Z. Msallaty, M. Caruso, M. K. Lewis, Z. Yi, M. P. Diamond, A. Badi Abou-Samra, et al. 2015. Plasma lactate levels increase during hyperinsulinemic euglycemic clamp and oral glucose tolerance test. Journal of Diabetes Research 2015:1–7. doi: 10.1155/2015/102054.
  • Bhagavan, N. V., and C.-E. Ha. 2011. Chapter 15 – Protein and amino acid metabolism. In Essentials of Medical Biochemistry Ha, eds. N. V. Bhagavan and C.-E. Ha, 169–90. San Diego: Academic Press. doi: 10.1016/B978-0-12-095461-2.00015-1.
  • Blalock, W., Lampsas, S., M. Xenou, E. Oikonomou, P. Pantelidis, A. Lysandrou, S. Sarantos, A. Goliopoulou, K. Kalogeras, V. Tsigkou, A. Kalpis, et al. 2023. Lipoprotein(a) in atherosclerotic diseases: From pathophysiology to diagnosis and treatment. Molecules 28 (3):969. doi: 10.3390/molecules28030969.
  • Bloomgarden, Z. 2018. Diabetes and branched-chain amino acids: What is the link? Journal of Diabetes. John Wiley and Sons Inc 10 (5):350–2. doi: 10.1111/1753-0407.12645.
  • Boccia, S., P. Boffetta, P. Brennan, G. Ricciardi, F. Gianfagna, K. Matsuo, C. M. van Duijn, and R. J. Hung. 2009. Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer. Cancer Letters 273 (1):55–61. doi: 10.1016/j.canlet.2008.07.026.
  • Brereton, M. F., M. Rohm, K. Shimomura, C. Holland, S. Tornovsky-Babeay, D. Dadon, M. Iberl, M. V. Chibalina, S. Lee, B. Glaser, et al. 2016. Hyperglycaemia induces metabolic dysfunction and glycogen accumulation in pancreatic β-cells. Nature Communications 7 (1):13496. doi: 10.1038/ncomms13496.
  • Broek, T. J., G. C. M. Bakker, C. M. Rubingh, S. Bijlsma, J. H. M. Stroeve, B. van Ommen, M. J. van Erk, and S. Wopereis. 2017. Ranges of phenotypic flexibility in healthy subjects. Genes & Nutrition 12 (1):32. doi: 10.1186/s12263-017-0589-8.
  • Broers, E. R., G. Gavidia, M. Wetzels, V. Ribas, I. Ayoola, J. Piera-Jimenez, J. W. Widdershoven, and M. Habibović. 2020. Usefulness of a lifestyle intervention in patients with cardiovascular disease. The American Journal of Cardiology 125 (3):370–5. doi: 10.1016/J.AMJCARD.2019.10.041.
  • Bumb, J. M., P. Bach, M. Grosshans, X. Wagner, A. Koopmann, S. Vollstädt-Klein, R. Schuster, K. Wiedemann, and F. Kiefer. 2021. BDNF influences neural cue-reactivity to food stimuli and food craving in obesity. European Archives of Psychiatry and Clinical Neuroscience 271 (5):963–74. doi: 10.1007/s00406-020-01224-w.
  • Calder, P. C. 2017. Omega-3 fatty acids and inflammatory processes: From molecules to man. Biochemical Society Transactions 45 (5):1105–15. doi: 10.1042/BST20160474.
  • Calder, P. C., N. Ahluwalia, R. Albers, N. Bosco, R. Bourdet-Sicard, D. Haller, S. T. Holgate, L. S. Jönsson, M. E. Latulippe, A. Marcos, et al. 2013. A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies. British Journal of Nutrition 109 (S1):S1–S34. doi: 10.1017/S0007114512005119.
  • Callahan, E. A. 2022. Challenges and opportunities for precision and personalized nutrition: proceedings of a workshop. In Challenges and opportunities for precision and personalized nutrition, April. National Academies Press. doi: 10.17226/26299.
  • Canfora, E. E., J. W. Jocken, and E. E. Blaak. 2015. Short-chain fatty acids in control of body weight and insulin sensitivity. Nature Reviews. Endocrinology 11 (10):577–91. doi: 10.1038/NRENDO.2015.128.
  • Carlessi, R., J. Rowlands, G. Ellison, H. Helena de Oliveira Alves, P. Newsholme, and C. Mamotte. 2019. Glutamine deprivation induces metabolic adaptations associated with beta cell dysfunction and exacerbate lipotoxicity. Molecular and Cellular Endocrinology 491:110433. doi: 10.1016/j.mce.2019.04.013.
  • Cena, H., and P. C. Calder. 2020. Defining a healthy diet: Evidence for the role of contemporary dietary patterns in health and disease. Nutrients 12 (2):334. doi: 10.3390/nu12020334.
  • Charles, B. A., A. Doumatey, H. Huang, J. Zhou, G. Chen, D. Shriner, A. Adeyemo, and C. N. Rotimi. 2011. The roles of IL-6, IL-10, and IL-1RA in obesity and insulin resistance in African-Americans. The Journal of Clinical Endocrinology and Metabolism 96 (12):E2018–E2022. doi: 10.1210/jc.2011-1497.
  • Chaudhary, N., V. Kumar, P. Sangwan, N. Chandra Pant, A. Saxena, S. Joshi, and A. Nath Yadav. 2021. Personalized nutrition and -omics. In Comprehensive foodomics, 495–507. doi: 10.1016/B978-0-08-100596-5.22880-1.
  • Chen, Y., M. Michalak, and L. B. Agellon. 2018. Importance of nutrients and nutrient metabolism on human health. The Yale Journal of Biology and Medicine 91 (2):95–103.
  • Chen, T., Y. Ni, X. Ma, Y. Bao, J. Liu, F. Huang, C. Hu, G. Xie, A. Zhao, W. Jia, et al. 2016. Branched-chain and aromatic amino acid profiles and diabetes risk in chinese populations. Scientific Reports 6 (1):20594. doi: 10.1038/srep20594.
  • Chen, L., D. Wang, S. Garmaeva, A. Kurilshikov, A. Vich Vila, R. Gacesa, T. Sinha, E. Segal, R. K. Weersma, C. Wijmenga, et al. 2021. The Long-term genetic stability and individual specificity of the human gut microbiome. Cell 184 (9):2302–15.e12. doi: 10.1016/J.CELL.2021.03.024.
  • Chew, N. W. S., C. H. Ng, D. J. H. Tan, G. Kong, C. Lin, Y. H. Chin, W. H. Lim, D. Q. Huang, J. Quek, C. E. Fu, et al. 2023. The global burden of metabolic disease: Data from 2000 to 2019. Cell Metabolism 35 (3):414–28.e3. doi: 10.1016/J.CMET.2023.02.003.
  • Chiesa, S. T., M. Charakida, G. Georgiopoulos, J. D. Roberts, S. J. Stafford, C. Park, J. Mykkänen, M. Kähönen, T. Lehtimäki, M. Ala-Korpela, et al. 2022. Glycoprotein acetyls: A novel inflammatory biomarker of early cardiovascular risk in the young. Journal of the American Heart Association 11 (4):24380. doi: 10.1161/JAHA.121.024380.
  • Choe, S. S., J. Y. Huh, I. J. Hwang, J. I. Kim, and J. B. Kim. 2016. Adipose tissue remodeling: Its role in energy metabolism and metabolic disorders. Frontiers in Endocrinology 7 (April):30. doi: 10.3389/fendo.2016.00030.
  • Choi, C. S., Y. B. Kim, F. N. Lee, J. M. Zabolotny, B. B. Kahn, and J. H. Youn. 2002. Lactate induces insulin resistance in skeletal muscle by suppressing glycolysis and impairing insulin signaling. American Journal of Physiology-Endocrinology and Metabolism 283 (2):E233–E240. doi: 10.1152/ajpendo.00557.2001.
  • Cirulli, E. T., L. Guo, C. Leon Swisher, N. Shah, L. Huang, L. A. Napier, E. F. Kirkness, T. D. Spector, C. T. Caskey, B. Thorens, et al. 2019. Profound perturbation of the metabolome in obesity is associated with health risk. Cell Metabolism 29 (2):488–500.e2. doi: 10.1016/j.cmet.2018.09.022.
  • Comuzzie, A. G., S. A. Cole, S. L. Laston, V. S. Voruganti, K. Haack, R. A. Gibbs, and N. F. Butte. 2012. Novel genetic loci identified for the pathophysiology of childhood obesity in the hispanic population. PloS One 7 (12):e51954. doi: 10.1371/journal.pone.0051954.
  • Connelly, M. A., E. G. Gruppen, J. Wolak-Dinsmore, S. P. Matyus, I. J. Riphagen, I. Shalaurova, S. J. Bakker, J. D. Otvos, and R. P. Dullaart. 2016. GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study. Clinica Chimica Acta; International Journal of Clinical Chemistry 452 (January):10–7. doi: 10.1016/j.cca.2015.11.001.
  • Connelly, M. A., J. D. Otvos, I. Shalaurova, M. P. Playford, and N. N. Mehta. 2017. GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk. Journal of Translational Medicine 15 (1):17. doi: 10.1186/s12967-017-1321-6.
  • Correa Rojo, A., D. Heylen, J. Aerts, O. Thas, J. Hooyberghs, G. Ertaylan, and D. Valkenborg. 2021. Towards building a quantitative proteomics toolbox in precision medicine: A mini-review. Frontiers in Physiology 12:723510. doi: 10.3389/fphys.2021.723510.
  • Cox, C. L., K. L. Stanhope, J. M. Schwarz, J. L. Graham, B. Hatcher, S. C. Griffen, A. A. Bremer, L. Berglund, J. P. McGahan, N. L. Keim, et al. 2012. Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans. Nutrition & Metabolism 9 (1):1. doi: 10.1186/1743-7075-9-68.
  • Crawford, S. O., R. C. Hoogeveen, F. L. Brancati, B. C. Astor, C. M. Ballantyne, M. I. Schmidt, and J. H. Young. 2010. Association of blood lactate with type 2 diabetes: The atherosclerosis risk in communities carotid MRI study. International Journal of Epidemiology 39 (6):1647–55. doi: 10.1093/ije/dyq126.
  • Custodero, C., R. T. Mankowski, S. A. Lee, Z. Chen, S. Wu, T. M. Manini, J. Hincapie Echeverri, C. Sabbà, D. P. Beavers, J. A. Cauley, et al. 2018. Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis. Ageing Research Reviews 46 (September):42–59. doi: 10.1016/J.ARR.2018.05.004.
  • da Silva, D. G. H., E. Belini Junior, L. de Souza Torres, J. V. Okumura, W. Marcel Barberino, R. Garcia de Oliveira, V. Urbinatti Teixeira, C. Lopes de Castro Lobo, E. Alves de Almeida, and C. R. Bonini-Domingos. 2017. Impact of genetic polymorphisms in key enzymes of homocysteine metabolism on the pathophysiology of sickle cell anemia. Free Radical Biology & Medicine 106 (May):53–61. doi: 10.1016/j.freeradbiomed.2017.02.019.
  • Dąbrowska, K., and W. Witkiewicz. 2016. Correlations of host genetics and gut microbiome composition. Frontiers in Microbiology 7 (Aug):1357. doi: 10.3389/FMICB.2016.01357/BIBTEX.
  • D’Angelo, S., I. C. Gormley, B. A. McNulty, A. P. Nugent, J. Walton, A. Flynn, and L. Brennan. 2019. Combining biomarker and food intake data: Calibration equations for citrus intake. The American Journal of Clinical Nutrition 110 (4):977–83. doi: 10.1093/ajcn/nqz168.
  • Dastani, Z., M.-F. Hivert, N. Timpson, J. R. B. Perry, X. Yuan, R. A. Scott, P. Henneman, I. M. Heid, J. R. Kizer, L.-P. Lyytikäinen, et al. 2012. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. Edited by Peter M. PLoS Genetics 8 (3):e1002607. doi: 10.1371/journal.pgen.1002607.
  • De Caterina, R., and A. El-Sohemy. 2016. Moving towards specific nutrigenetic recommendation algorithms: Caffeine, genetic variation and cardiovascular risk. Journal of Nutrigenetics and Nutrigenomics 9 (2-4):106–15. doi: 10.1159/000446801.
  • de Toro-Martín, J., B. J. Arsenault, J. P. Després, and M. C. Vohl. 2017. Precision nutrition: A review of personalized nutritional approaches for the prevention and management of metabolic syndrome. Nutrients 9 (8):913. doi: 10.3390/nu9080913.
  • Dehghan, P., M. A. Farhangi, L. Nikniaz, Z. Nikniaz, and M. Asghari-Jafarabadi. 2020. Gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) potentially increases the risk of obesity in adults: An exploratory systematic review and dose-response meta-analysis. Obesity Reviews 21 (5): e12993. doi: 10.1111/obr.12993.
  • Del Bas, J. M., A. Caimari, M. I. Rodriguez-Naranjo, C. E. Childs, C. Paras Chavez, A. L. West, E. A. Miles, L. Arola, and P. C. Calder. 2016. Impairment of lysophospholipid metabolism in obesity: Altered plasma profile and desensitization to the modulatory properties of n-3 polyunsaturated fatty acids in a randomized controlled trial. The American Journal of Clinical Nutrition 104 (2):266–79. doi: 10.3945/ajcn.116.130872.
  • Di Minno, A., L. Turnu, B. Porro, I. Squellerio, V. Cavalca, E. Tremoli, and M. N. D. Di Minno. 2016. 8-Hydroxy-2-deoxyguanosine levels and cardiovascular disease: A systematic review and meta-analysis of the literature. Antioxidants & Redox Signaling 24 (10):548–55. doi: 10.1089/ars.2015.6508.
  • Djuricic, I., and P. C. Calder. 2021. Beneficial outcomes of omega-6 and omega-3 polyunsaturated fatty acids on human health: An update for 2021. Nutrients 13 (7):2421. doi: 10.3390/nu13072421.
  • Donovan, S. M. 2017. Introduction to the special focus issue on the impact of diet on gut microbiota composition and function and future opportunities for nutritional modulation of the gut microbiome to improve human health. Gut Microbes 8 (2):75–81. doi: 10.1080/19490976.2017.1299309.
  • Dorajoo, R., Y. Sun, Y. Han, T. Ke, A. Burger, X. Chang, H. Q. Low, W. Guan, R. N. Lemaitre, C.-C. Khor, et al. 2015. A genome-wide association study of n-3 and n-6 plasma fatty acids in a Singaporean Chinese population. Genes & Nutrition 10 (6):53. doi: 10.1007/s12263-015-0502-2.
  • Dorcely, B., K. Katz, R. Jagannathan, S. S. Chiang, B. Oluwadare, I. J. Goldberg, and M. Bergman. 2017. Novel biomarkers for prediabetes, diabetes, and associated complications. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 10 (August):345–61. doi: 10.2147/DMSO.S100074.
  • Dragsted, L. O., Q. Gao, A. Scalbert, G. Vergères, M. Kolehmainen, C. Manach, L. Brennan, L. A. Afman, D. S. Wishart, C. A. Lacueva, et al. 2018. Validation of biomarkers of food intake—Critical assessment of candidate biomarkers. Genes & Nutrition 13 (1):14. doi: 10.1186/s12263-018-0603-9.
  • Draisma, H. H. M., R. Pool, M. Kobl, R. Jansen, A.-K. Petersen, A. A. M. Vaarhorst, I. Yet, T. Haller, A. Demirkan, T. Esko, et al. 2015. Genome-wide association study identifies novel genetic variants contributing to variation in blood metabolite levels. Nature Communications 6 (June):7208. doi: 10.1038/ncomms8208.
  • Du, S., S. Sun, L. Liu, Q. Zhang, F. Guo, C. Li, R. Feng, and C. Sun. 2017. Effects of histidine supplementation on global serum and urine 1H NMR-based metabolomics and serum amino acid profiles in obese women from a randomized controlled study. Journal of Proteome Research 16 (6):2221–30. doi: 10.1021/acs.jproteome.7b00030.
  • EFSA Panel on Dietetic Products. Nutrition and Allergies (NDA). 2012a. Guidance on the scientific requirements for health claims related to appetite ratings, weight management, and blood glucose concentrations. EFSA Journal 10 (3):2604. doi: 10.2903/j.efsa.2012.2604.
  • EFSA Panel on Dietetic Products. Nutrition and Allergies (NDA). 2012b. Guidance on the scientific requirements for health claims related to bone, joints, skin, and oral health. EFSA Journal 10 (5):2702. doi: 10.2903/J.EFSA.2012.2702.
  • EFSA Panel on Dietetic Products. Nutrition and Allergies (NDA). 2012c. Guidance on the scientific requirements for health claims related to functions of the nervous system, including psychological functions. EFSA Journal 10 (7): 2816. doi: 10.2903/J.EFSA.2012.2816.
  • EFSA Panel on Dietetic Products. Nutrition and Allergies (NDA). 2016. Guidance on the scientific requirements for health claims related to the immune system, the gastrointestinal tract and defence against pathogenic microorganisms. EFSA Journal 14 (1): 4369. doi: 10.2903/J.EFSA.2016.4369.
  • Elliott, R., C. Pico, Y. Dommels, I. Wybranska, J. Hesketh, and J. Keijer. 2007. Nutrigenomic approaches for benefit-risk analysis of foods and food components: Defining markers of health. The British Journal of Nutrition 98 (6):1095–100. doi: 10.1017/S0007114507803400.
  • Emwas, A. H., R. Roy, R. T. McKay, L. Tenori, E. Saccenti, G. A. N. Gowda, D. Raftery, F. Alahmari, L. Jaremko, M. Jaremko, et al. 2019. NMR spectroscopy for metabolomics research. Metabolites 9 (7):123. doi: 10.3390/metabo9070123.
  • Erlanson-Albertsson, C., and K. G. Stenkula. 2021. The importance of food for endotoxemia and an inflammatory response. International Journal of Molecular Sciences 22 (17):9562. doi: 10.3390/ijms22179562.
  • EUR-Lex. 2014. Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on Nutrition and Health Claims Made on Foods.
  • Fernández-Calleja, J. M., P. Konstanti, H. J. Swarts, L. M. Bouwman, V. Garcia-Campayo, N. Billecke, A. Oosting, H. Smidt, J. Keijer, and E. M. van Schothorst. 2018. Non-invasive continuous real-time in vivo analysis of microbial hydrogen production shows adaptation to fermentable carbohydrates in mice. Scientific Reports 8 (1):1–16. doi: 10.1038/s41598-018-33619-0.
  • Ferreri, C., A. Masi, A. Sansone, G. Giacometti, A. V. Larocca, G. Menounou, R. Scanferlato, S. Tortorella, D. Rota, M. Conti, et al. 2016. Fatty acids in membranes as homeostatic, metabolic and nutritional biomarkers: recent advancements in analytics and diagnostics. Diagnostics 7 (1):1. doi: 10.3390/diagnostics7010001.
  • Finucane, F. M., J. Luan, N. J. Wareham, S. J. Sharp, S. O’Rahilly, B. Balkau, A. Flyvbjerg, M. Walker, K. Højlund, J. J. Nolan, et al. 2009. Correlation of the leptin: Adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 52 (11):2345–9. doi: 10.1007/s00125-009-1508-3.
  • Floris, M., A. Cano, L. Porru, R. Addis, A. Cambedda, M. L. Idda, M. Steri, C. Ventura, and M. Maioli. 2020. Direct-to-consumer nutrigenetics testing: An overview. Nutrients 12 (2):566. doi: 10.3390/nu12020566.
  • Forouhi, N. G., and N. Unwin. 2019. Global diet and health: Old questions, fresh evidence, and new horizons. The Lancet 393 (10184):1916–8. doi: 10.1016/S0140-6736(19)30500-8.
  • Frayling, T. M., N. J. Timpson, M. N. Weedon, E. Zeggini, R. M. Freathy, C. M. Lindgren, J. R. B. Perry, K. S. Elliott, H. Lango, N. W. Rayner, et al. 2007. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (New York, N.Y.) 316 (5826):889–94. doi: 10.1126/science.1141634.
  • Freeman, A. M., and N. Pennings. 2022. Insulin resistance. Treasure Island (FL).
  • Gakidou, E., A. Afshin, A. A. Abajobir, K. H. Abate, C. Abbafati, K. M. Abbas, F. Abd-Allah, A. M. Abdulle, S. F. Abera, V. Aboyans, et al. 2017. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: A systematic analysis for the global burden of disease study 2016. The Lancet 390 (10100):1345–422. doi: 10.1016/S0140-6736(17)32366-8.
  • Galmés, S., M. Cifre, A. Palou, P. Oliver, and F. Serra. 2019. A genetic score of predisposition to low-grade inflammation associated with obesity may contribute to discern population at risk for metabolic syndrome. Nutrients 11 (2):298. doi: 10.3390/nu11020298.
  • Galmés, S., A. Palou, and F. Serra. 2020. Increased risk of high body fat and altered lipid metabolism associated to suboptimal consumption of vitamin a is modulated by genetic variants Rs5888 (Scarb1), Rs1800629 (Ucp1) and Rs659366 (Ucp2). Nutrients 12 (9):2588. doi: 10.3390/nu12092588.
  • Galmés, S., F. Serra, and A. Palou. 2018. Vitamin E metabolic effects and genetic variants: A challenge for precision nutrition in obesity and associated disturbances. Nutrients 10 (12):1919. doi: 10.3390/nu10121919.
  • Galmés, S., F. Serra, and A. Palou. 2020. Current state of evidence: Influence of nutritional and nutrigenetic factors on immunity in the COVID-19 pandemic framework. Nutrients 12 (9):2738. doi: 10.3390/nu12092738.
  • Gannon, N. P., J. K. Schnuck, and R. A. Vaughan. 2018. BCAA metabolism and insulin sensitivity – dysregulated by metabolic status? Molecular Nutrition & Food Research 62 (6):1700756. doi: 10.1002/mnfr.201700756.
  • Garcia-Aloy, M., M. Rabassa, P. Casas-Agustench, N. Hidalgo-Liberona, R. Llorach, and C. Andres-Lacueva. 2017. Novel strategies for improving dietary exposure assessment: Multiple-data fusion is a more accurate measure than the traditional single-biomarker approach. Trends in Food Science & Technology 69 (November):220–9. doi: 10.1016/j.tifs.2017.04.013.
  • Garcia-Perez, I., J. M. Posma, E. S. Chambers, J. C. Mathers, J. Draper, M. Beckmann, J. K. Nicholson, E. Holmes, and G. Frost. 2020. Dietary metabotype modelling predicts individual responses to dietary interventions. Nature Food 1 (6):355–64. doi: 10.1038/s43016-020-0092-z.
  • Gart, E., W. van Duyvenvoorde, K. Toet, M. P. Caspers, L. Verschuren, M. J. Nielsen, D. J. Leeming, E. Souto Lima, A. Menke, R. Hanemaaijer, et al. 2021. Butyrate protects against diet-induced NASH and liver fibrosis and suppresses specific non-canonical TGF-β signaling pathways in human hepatic stellate cells. Biomedicines 9 (12):1954. doi: 10.3390/biomedicines9121954.
  • Ge, X., L. Zheng, R. Zhuang, P. Yu, Z. Xu, G. Liu, X. Xi, X. Zhou, and H. Fan. 2020. The gut microbial metabolite trimethylamine N-oxide and hypertension risk: A systematic review and dose-response meta-analysis. Advances in Nutrition 11 (1):66–76. doi: 10.1093/advances/nmz064.
  • Gentile, C. L., and T. L. Weir. 2018. The gut microbiota at the intersection of diet and human health. Science (New York, N.Y.) 362 (6416):776–80. doi: 10.1126/science.aau5812.
  • Gkouskou, K. K., M. G. Grammatikopoulou, I. Vlastos, D. Sanoudou, and A. G. Eliopoulos. 2021. Genotype-guided dietary supplementation in precision nutrition. Nutrition Reviews 79 (11):1225–35. doi: 10.1093/nutrit/nuaa132.
  • Gogna, N., M. Krishna, A. M. Oommen, and K. Dorai. 2015. Investigating correlations in the altered metabolic profiles of obese and diabetic subjects in a South Indian Asian Population using an NMR-based metabolomic approach. Molecular bioSystems 11 (2):595–606. doi: 10.1039/C4MB00507D.
  • Goldberg, R. B., G. A. Bray, S. M. Marcovina, K. J. Mather, T. J. Orchard, L. Perreault, and M. Temprosa. 2019. Non-traditional biomarkers and incident diabetes in the diabetes prevention program: comparative effects of lifestyle and metformin interventions. Diabetologia 62 (1):58–69. doi: 10.1007/s00125-018-4748-2.
  • González Jiménez, E. 2011. Genes and obesity: A cause and effect relationship. Endocrinologia y Nutricion: organo de la Sociedad Espanola de Endocrinologia y Nutricion 58 (9):492–6. doi: 10.1016/j.endonu.2011.06.004.
  • González-Domínguez, R., O. Jáuregui, P. Mena, K. Hanhineva, F. J. Tinahones, D. Angelino, and C. Andrés-Lacueva. 2020. Quantifying the human diet in the crosstalk between nutrition and health by multi-targeted metabolomics of food and microbiota-derived metabolites. International Journal of Obesity (2005) 44 (12):2372–81. doi: 10.1038/S41366-020-0628-1.
  • González-Domínguez, R., M. Urpi-Sarda, O. Jáuregui, P. W. Needs, P. A. Kroon, and C. Andrés-Lacueva. 2020. Quantitative dietary fingerprinting (QDF)-a novel tool for comprehensive dietary assessment based on urinary nutrimetabolomics. Journal of Agricultural and Food Chemistry 68 (7):1851–61. doi: 10.1021/acs.jafc.8b07023.
  • Gonzalez-Franquesa, A., A. M. Burkart, E. Isganaitis, and M.-E. Patti. 2016. What have metabolomics approaches taught us about type 2 diabetes? Current Diabetes Reports 16 (8):74. doi: 10.1007/s11892-016-0763-1.
  • Goodarzi, M. O. 2018. Genetics of obesity: What genetic association studies have taught us about the biology of obesity and its complications. The Lancet. Diabetes & Endocrinology 6 (3):223–36. doi: 10.1016/S2213-8587(17)30200-0.
  • Gschwandtner, M., R. Derler, and K. S. Midwood. 2019. More than just attractive: How CCL2 influences myeloid cell behavior beyond chemotaxis. Frontiers in Immunology 10(December):2759. doi: 10.3389/FIMMU.2019.02759/BIBTEX.
  • Guasch-Ferré, M., A. Hruby, E. Toledo, C. B. Clish, M. A. Martínez-González, J. Salas-Salvadó, and F. B. Hu. 2016. Metabolomics in prediabetes and diabetes: A systematic review and meta-analysis. Diabetes Care 39 (5):833–46. doi: 10.2337/dc15-2251.
  • Guasch-Ferré, M., and W. C. Willett. 2021. The Mediterranean diet and health: A comprehensive overview. Journal of Internal Medicine 290 (3):549–66. doi: 10.1111/JOIM.13333.
  • Guasti, L., S. Galliazzo, M. Molaro, E. Visconti, B. Pennella, G. V. Gaudio, A. Lupi, A. M. Grandi, and A. Squizzato. 2021. TMAO as a biomarker of cardiovascular events: A systematic review and meta-analysis. Internal and Emergency Medicine 16 (1):201–7. doi: 10.1007/s11739-020-02470-5.
  • Ha, C. Y., J. Y. Kim, J. K. Paik, O. Y. Kim, Y.-H. Paik, E. J. Lee, and J. H. Lee. 2012. The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes. Clinical Endocrinology 76 (5):674–82. doi: 10.1111/j.1365-2265.2011.04244.x.
  • Hageman, J. H. J., A. G. Nieuwenhuizen, S. M. van Ruth, J. A. Hageman, and J. Keijer. 2019. Application of volatile organic compound analysis in a nutritional intervention study: differential responses during five hours following consumption of a high- and a low-fat dairy drink. Molecular Nutrition & Food Research 63 (20):e1900189. doi: 10.1002/mnfr.201900189.
  • Hammad, S., S. Pu, and P. J. Jones. 2016. Current evidence supporting the link between dietary fatty acids and cardiovascular disease. Lipids 51 (5):507–17. doi: 10.1007/s11745-015-4113-x.
  • Hartiala, J. A., W. H. Wilson Tang, Z. Wang, A. L. Crow, A. F. R. Stewart, R. Roberts, R. McPherson, J. Erdmann, C. Willenborg, S. L. Hazen, et al. 2016. Genome-wide association study and targeted metabolomics identifies sex-specific association of CPS1 with coronary artery disease. Nature Communications 7 (1):10558. doi: 10.1038/ncomms10558.
  • Hasani, M., A. Mansour, H. Asayesh, S. Djalalinia, A. Mahdavi Gorabi, F. Ochi, and M. Qorbani. 2021. Effect of glutamine supplementation on cardiometabolic risk factors and inflammatory markers: A systematic review and meta-analysis. BMC Cardiovascular Disorders 21 (1): 190. doi: 10.1186/s12872-021-01986-8.
  • Heianza, Y., W. Ma, J. A. E. Manson, K. M. Rexrode, and L. Qi. 2017. Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: A systematic review and meta-analysis of prospective studies. Journal of the American Heart Association 6 (7):4947. doi: 10.1161/JAHA.116.004947.
  • Hernandez-Baixauli, J., S. Quesada-Vázquez, R. Mariné-Casadó, K. Gil Cardoso, A. Caimari, J. M. Del Bas, X. Escoté, and L. Baselga-Escudero. 2020. Detection of early disease risk factors associated with metabolic syndrome: A new era with the NMR metabolomics assessment. Nutrients 12 (3):806. doi: 10.3390/nu12030806.
  • Hoevenaars, F., J. W. van der Kamp, W. D. van den Brink, and S. Wopereis. 2020. Next generation health claims based on resilience: The example of whole-grain wheat. Nutrients 12 (10):2945. doi: 10.3390/nu12102945.
  • Hoffmann, T. J., E. Theusch, T. Haldar, D. K. Ranatunga, E. Jorgenson, M. W. Medina, M. N. Kvale, P.-Y. Kwok, C. Schaefer, R. M. Krauss, et al. 2018. A large electronic-health-record-based genome-wide study of serum lipids. Nature Genetics 50 (3):401–13. doi: 10.1038/s41588-018-0064-5.
  • Hopkins, M. H., W. D. Flanders, and R. M. Bostick. 2012. Associations of circulating inflammatory biomarkers with risk factors for colorectal cancer in colorectal adenoma Patients. Biomarker Insights 7:143–50. doi: 10.4137/BMI.S10092.
  • Hou, K., Z.-X. Wu, X.-Y. Chen, J.-Q. Wang, D. Zhang, C. Xiao, D. Zhu, J. B. Koya, L. Wei, J. Li, et al. 2022. Microbiota in health and diseases. Signal Transduction and Targeted Therapy 7 (1):135. doi: 10.1038/s41392-022-00974-4.
  • Htun, K. T., J. Pan, D. Pasanta, M. Tungjai, C. Udomtanakunchai, S. Chancharunee, S. Kaewjaeng, H. J. Kim, J. Kaewkhao, and S. Kothan. 2021. Identification of metabolic phenotypes in young adults with obesity by 1H NMR metabolomics of blood serum. Life 11 (6):574. doi: 10.3390/life11060574.
  • Huber, M., J. A. Knottnerus, L. Green, H. Horst, A. R. Jadad, D. Kromhout, B. Leonard, K. Lorig, M. I. Loureiro, J. W. M. Meer, et al. 2011. How should we define health? BMJ (Clinical Research Ed.) 343 (jul26 2):d4163–d4163. doi: 10.1136/bmj.d4163.
  • Huffman, K. M., S. H. Shah, R. D. Stevens, J. R. Bain, M. Muehlbauer, C. A. Slentz, C. J. Tanner, M. Kuchibhatla, J. A. Houmard, C. B. Newgard, et al. 2009. Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care 32 (9):1678–83. doi: 10.2337/dc08-2075.
  • Hüls, A., U. Krämer, C. Carlsten, T. Schikowski, K. Ickstadt, and H. Schwender. 2017. Comparison of weighting approaches for genetic risk scores in gene-environment interaction studies. BMC Genetics 18 (1):115. doi: 10.1186/s12863-017-0586-3.
  • Hysi, P. G., A. P. Khawaja, C. Menni, B. Tamraz, N. Wareham, K.-T. Khaw, P. J. Foster, L. Z. Benet, T. D. Spector, and C. J. Hammond. 2019. Ascorbic acid metabolites are involved in intraocular pressure control in the general population. Redox Biology 20 (January):349–53. doi: 10.1016/j.redox.2018.10.004.
  • Hysi, P. G., M. Mangino, P. Christofidou, M. Falchi, E. D. Karoly, A. M. Mohney, T. D. Valdes, C. Spector, and Menni, R. P. 2022. Metabolome genome-wide association study identifies 74 novel genomic regions influencing plasma metabolites levels. Metabolites 12 (1):61. doi: 10.3390/metabo12010061.
  • Il’yasova, D., P. Scarbrough, and I. Spasojevic. 2012. Urinary biomarkers of oxidative status. Clinica Chimica Acta 413 (19-20):1446–53. doi: 10.1016/j.cca.2012.06.012.
  • Illig, T., C. Gieger, G. Zhai, W. Römisch-Margl, R. Wang-Sattler, C. Prehn, E. Altmaier, G. Kastenmüller, B. S. Kato, H.-W. Mewes, et al. 2010. A genome-wide perspective of genetic variation in human metabolism. Nature Genetics 42 (2):137–41. doi: 10.1038/ng.507.
  • Imaizumi, A., Y. Adachi, T. Kawaguchi, K. Higasa, Y. Tabara, K. Sonomura, T.-A. Sato, M. Takahashi, T. Mizukoshi, H.-O. Yoshida, et al. 2019. Genetic basis for plasma amino acid concentrations based on absolute quantification: A genome-wide association study in the Japanese population. European Journal of Human Genetics: EJHG 27 (4):621–30. doi: 10.1038/s41431-018-0296-y.
  • Jahangiri, A. 2010. High-density lipoprotein and the acute phase response. Current Opinion in Endocrinology, Diabetes, and Obesity 17 (2):156–60. doi: 10.1097/MED.0b013e328337278b.
  • Jang, Y. N., J. H. Lee, J. S. Moon, D. R. Kang, S. Y. Park, J. Cho, J. Y. Kim, and J. H. Huh. 2021. Metabolic syndrome severity score for predicting cardiovascular events: A nationwide population-based study from Korea. Diabetes & Metabolism Journal 45 (4):569–77. doi: 10.4093/DMJ.2020.0103.
  • Jang, C., S. F. Oh, S. Wada, G. C. Rowe, L. Liu, M. C. Chan, J. Rhee, A. Hoshino, B. Kim, A. Ibrahim, et al. 2016. A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nature Medicine 22 (4):421–6. doi: 10.1038/nm.4057.
  • Janssen, J. J. E., B. Lagerwaard, A. G. Nieuwenhuizen, X. Escoté, N. Canela, J. M. Del Bas, V. C. J. de Boer, and J. Keijer. 2023. Single and joined behaviour of circulating biomarkers and metabolic parameters in high-fit and low-fit healthy females. International Journal of Molecular Sciences 24 (4):4202. doi: 10.3390/ijms24044202.
  • Janssen, J. J. E., B. Lagerwaard, A. G. Nieuwenhuizen, S. Timmers, V. C. J. de Boer, and J. Keijer. 2021. The effect of a single bout of exercise on vitamin B2 status is not different between high- and low-fit females. Nutrients 13 (11):4097. doi: 10.3390/nu13114097.
  • Jauregibeitia, I., K. Portune, I. Rica, I. Tueros, O. Velasco, G. Grau, L. Castaño, F. Di Nolfo, C. Ferreri, and S. Arranz. 2021. Potential of erythrocyte membrane lipid profile as a novel inflammatory biomarker to distinguish metabolically healthy obesity in children. Journal of Personalized Medicine 11 (5):337. doi: 10.3390/jpm11050337.
  • Jauregibeitia, I., K. Portune, I. Rica, I. Tueros, O. Velasco, G. Grau, N. Trebolazabala, L. Castaño, A. V. Larocca, C. Ferreri, et al. 2020. Fatty acid profile of mature red blood cell membranes and dietary intake as a new approach to characterize children with overweight and obesity. Nutrients 12 (11):3446. doi: 10.3390/nu12113446.
  • Jayedi, A., A. Rashidy-Pour, M. Parohan, M. Sadat Zargar, and S. Shab-Bidar. 2018. Dietary antioxidants, circulating antioxidant concentrations, total antioxidant capacity, and risk of all-cause mortality: A systematic review and dose-response meta-analysis of prospective observational studies. Advances in Nutrition (Bethesda, Md.) 9 (6):701–16. doi: 10.1093/ADVANCES/NMY040.
  • Jerotic, D., M. Matic, S. Suvakov, K. Vucicevic, T. Damjanovic, A. Savic-Radojevic, M. Pljesa-Ercegovac, V. Coric, A. Stefanovic, J. Ivanisevic, et al. 2019. Association of Nrf2, SOD2 and GPX1 polymorphisms with biomarkers of oxidative distress and survival in end-stage renal disease patients. Toxins 11 (7):431. doi: 10.3390/toxins11070431.
  • Jia, Z., X. Zhang, S. Kang, and Y. Wu. 2013. Serum uric acid levels and incidence of impaired fasting glucose and type 2 diabetes mellitus: A meta-analysis of cohort studies. Diabetes Research and Clinical Practice 101 (1):88–96. doi: 10.1016/j.diabres.2013.03.026.
  • Jiang, S., H. Liu, and C. Li. 2021. Dietary regulation of oxidative stress in chronic metabolic diseases. Foods 10 (8):1854. doi: 10.3390/foods10081854.
  • Jiang, R., S. Wu, C. Fang, C. Wang, Y. Yang, C. Liu, J. Hu, and Y. Huang. 2020. Amino acids levels in early pregnancy predict subsequent gestational diabetes. Journal of Diabetes 12 (7):503–11. doi: 10.1111/1753-0407.13018.
  • Johnson, R. J., S. E. Perez-Pozo, J. L. Lillo, F. Grases, J. D. Schold, M. Kuwabara, Y. Sato, A. A. Hernando, G. Garcia, T. Jensen, et al. 2018. Fructose increases risk for kidney stones: Potential role in metabolic syndrome and heat stress. BMC Nephrology 19 (1):1–7. doi: 10.1186/s12882-018-1105-0.
  • Kathiresan, S., C. J. Willer, G. M. Peloso, S. Demissie, K. Musunuru, E. E. Schadt, L. Kaplan, D. Bennett, Y. Li, T. Tanaka, et al. 2009. Common variants at 30 loci contribute to polygenic dyslipidemia. Nature Genetics 41 (1):56–65. doi: 10.1038/ng.291.Common.
  • Keller, K. L. 2012. Genetic influences on oral fat perception and preference. Journal of Food Science 77 (3):S143–S147. doi: 10.1111/j.1750-3841.2011.02585.x.
  • Kettunen, J., A. Demirkan, P. Würtz, H. H. M. Draisma, T. Haller, R. Rawal, A. Vaarhorst, A. J. Kangas, L.-P. Lyytikäinen, M. Pirinen, et al. 2016. Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nature Communications 7 (March):11122. doi: 10.1038/ncomms11122.
  • Khakimov, B., H. C. J. Hoefsloot, N. Mobaraki, V. Aru, M. Kristensen, M. V. Lind, L. Holm, J. L. Castro-Mejía, D. S. Nielsen, D. M. Jacobs, et al. 2022. Human blood lipoprotein predictions from (1)H NMR spectra: Protocol, model performances, and cage of covariance. Analytical Chemistry 94 (2):628–36. doi: 10.1021/acs.analchem.1c01654.
  • Khera, A. V., M. Chaffin, K. H. Wade, S. Zahid, J. Brancale, R. Xia, M. Distefano, O. Senol-Cosar, M. E. Haas, A. Bick, et al. 2019. Polygenic prediction of weight and obesity trajectories from birth to adulthood. Cell 177 (3):587–96.e9. doi: 10.1016/j.cell.2019.03.028.
  • Kihara, A. 2012. Very long-chain fatty acids: Elongation, physiology and related disorders. Journal of Biochemistry 152 (5):387–95. doi: 10.1093/JB/MVS105.
  • Kilpeläinen, T. O., J. F. M. Carli, A. A. Skowronski, Q. Sun, J. Kriebel, M. F. Feitosa, Å. K. Hedman, A. W. Drong, J. E. Hayes, J. Zhao, et al. 2016. Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels. Nature Communications 7 (February):10494. doi: 10.1038/ncomms10494.
  • Kim, J.-Y., J.-W. Lee, Y.-J. Youn, M.-S. Ahn, S.-G. Ahn, B.-S. Yoo, S.-H. Lee, J. Yoon, and K.-H. Choe. 2012. Urinary levels of 8-iso-prostaglandin F2α and 8-hydroxydeoxyguanine as markers of oxidative stress in patients with coronary artery disease. Korean Circulation Journal 42 (9):614–7. doi: 10.4070/kcj.2012.42.9.614.
  • Kim, G. Y., and J.-S. Seo. 2021. A new paradigm for clinical nutrition services in the era of the fourth industrial revolution. Clinical Nutrition Research 10 (2):95–106. doi: 10.7762/cnr.2021.10.2.95.
  • Klisic, A., N. Kavaric, S. Vujcic, V. Spasojevic-Kalimanovska, J. Kotur-Stevuljevic, and A. Ninic. 2021. Factorial analysis of the cardiometabolic risk influence on redox status components in adult population. Oxidative Medicine and Cellular Longevity 2021:1–9. doi: 10.1155/2021/6661940.
  • Klop, B., J. W. F. Elte, and M. C. Cabezas. 2013. Dyslipidemia in obesity: Mechanisms and potential targets. Nutrients 5 (4):1218–40. doi: 10.3390/nu5041218.
  • Kodama, S., K. Saito, Y. Yachi, M. Asumi, A. Sugawara, K. Totsuka, A. Saito, and H. Sone. 2009. Association between serum uric acid and development of type 2 diabetes. Diabetes Care 32 (9):1737–42. doi: 10.2337/dc09-0288.
  • Korem, T., D. Zeevi, N. Zmora, O. Weissbrod, N. Bar, M. Lotan-Pompan, T. Avnit-Sagi, N. Kosower, G. Malka, M. Rein, et al. 2017. Bread affects clinical parameters and induces gut microbiome-associated personal glycemic responses. Cell Metabolism 25 (6):1243–53.e5. doi: 10.1016/j.cmet.2017.05.002.
  • Korpela, K., H. J. Flint, A. M. Johnstone, J. Lappi, K. Poutanen, E. Dewulf, N. Delzenne, W. M. de Vos, and A. Salonen. 2014. Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PloS One 9 (6):e90702. doi: 10.1371/journal.pone.0090702.
  • Koves, T. R., P. Li, J. An, T. Akimoto, D. Slentz, O. Ilkayeva, G. L. Dohm, Z. Yan, C. B. Newgard, and D. M. Muoio. 2005. Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. The Journal of Biological Chemistry 280 (39):33588–98. doi: 10.1074/jbc.M507621200.
  • Kroese, L. J., and P. G. Scheffer. 2014. 8-hydroxy-2′-deoxyguanosine and cardiovascular disease: A systematic review. Current Atherosclerosis Reports 16 (11): 452. doi: 10.1007/s11883-014-0452-y.
  • Kulminski, A. M., J. Huang, Y. Loika, K. G. Arbeev, O. Bagley, A. Yashkin, M. Duan, and I. Culminskaya. 2018. Strong impact of natural-selection-free heterogeneity in genetics of age-related phenotypes. Aging 10 (3):492–514. doi: 10.18632/aging.101407.
  • Laddu, D., and M. Hauser. 2019. Addressing the nutritional phenotype through personalized nutrition for chronic disease prevention and management. Progress in Cardiovascular Diseases 62 (1):9–14. doi: 10.1016/j.pcad.2018.12.004.
  • Lagerwaard, B., A. G. Nieuwenhuizen, V. C. de Boer, and J. Keijer. 2020. In vivo assessment of mitochondrial capacity using NIRS in locomotor muscles of young and elderly males with similar physical activity levels. GeroScience 42 (1):299–310. doi: 10.1007/S11357-019-00145-4.
  • Lagerwaard, B., M. D. van der Hoek, J. Hoeks, L. Grevendonk, A. G. Nieuwenhuizen, J. Keijer, and V. C. J. de Boer. 2021. Propionate hampers differentiation and modifies histone propionylation and acetylation in skeletal muscle cells. Mechanisms of Ageing and Development 196 (April):111495. doi: 10.1016/j.mad.2021.111495.
  • Laíns, I., D. Duarte, A. S. Barros, A. S. Martins, T. J. Carneiro, J. Q. Gil, J. B. Miller, M. Marques, T. S. Mesquita, P. Barreto, et al. 2019. Urine nuclear magnetic resonance (NMR) metabolomics in age-related macular degeneration. Journal of Proteome Research 18 (3):1278–88. doi: 10.1021/ACS.JPROTEOME.8B00877/SUPPL_FILE/PR8B00877_SI_001.PDF.
  • Lam, T. J., and Y. Ye. 2022. Meta-analysis of microbiome association networks reveal patterns of dysbiosis in diseased microbiomes. Scientific Reports 12 (1):17482. doi: 10.1038/s41598-022-22541-1.
  • Le Lay, S., G. Simard, M. C. Martinez, and R. Andriantsitohaina. 2014. Oxidative stress and metabolic pathologies: From an adipocentric point of view. Oxidative Medicine and Cellular Longevity 2014:1–18. doi: 10.1155/2014/908539.
  • Lek, F.-Y., H.-H. Ong, and Y.-H. Say. 2018. Association of dopamine receptor D2 gene (DRD2) Taq1 polymorphisms with eating behaviors and obesity among Chinese and Indian Malaysian university students. Asia Pacific Journal of Clinical Nutrition 27 (3):707–17. doi: 10.6133/apjcn.092017.09.
  • Leon-Cabrera, S., Y. Arana-Lechuga, E. Esqueda-León, G. Terán-Pérez, A. Gonzalez-Chavez, G. Escobedo, and J. Velázquez Moctezuma. 2015. Reduced systemic levels of {IL}-10 are associated with the severity of obstructive sleep apnea and insulin resistance in morbidly obese humans. Mediators of Inflammation 2015:493409. doi: 10.1155/2015/493409.
  • Ligthart, S., A. Vaez, U. Võsa, M. G. Stathopoulou, P. S. de Vries, B. P. Prins, P. J. Van der Most, T. Tanaka, E. Naderi, L. M. Rose, et al. 2018. Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders. American Journal of Human Genetics 103 (5):691–706. doi: 10.1016/j.ajhg.2018.09.009.
  • Li, D., Y. Lu, S. Yuan, X. Cai, Y. He, J. Chen, Q. Wu, D. He, A. Fang, Y. Bo, et al. 2022. Gut microbiota-derived metabolite trimethylamine-n-oxide and multiple health outcomes: An umbrella review and updated meta-analysis. The American Journal of Clinical Nutrition 116 (1):230–43. doi: 10.1093/ajcn/nqac074.
  • Li, G., T. D. Petkova, E. Laritsky, N. Kessler, M. S. Baker, S. Zhu, and R. A. Waterland. 2019. Early postnatal overnutrition accelerates aging-associated epigenetic drift in pancreatic islets. Environmental Epigenetics 5 (3):dvz015. doi: 10.1093/eep/dvz015.
  • Li, T., X.-P. Zhao, L.-Y. Wang, S. Gao, J. Zhao, Y.-C. Fan, and K. Wang. 2013. Glutathione S-transferase P1 correlated with oxidative stress in hepatocellular carcinoma. International Journal of Medical Sciences 10 (6):683–90. doi: 10.7150/ijms.5947.
  • Ljungman, P., T. Bellander, F. Nyberg, E. Lampa, B. Jacquemin, M. Kolz, T. Lanki, J. Mitropoulos, M. Müller, S. Picciotto, et al. 2009. DNA variants, plasma levels and variability of interleukin-6 in myocardial infarction survivors: results from the AIRGENE study. Thrombosis Research 124 (1):57–64. doi: 10.1016/j.thromres.2008.10.009.
  • Long, B., R. Muhamad, G. Yan, J. Yu, Q. Fan, Z. Wang, X. Li, A. Purnomoadi, J. Achmadi, and X. Yan. 2016. Quantitative proteomics analysis reveals glutamine deprivation activates fatty acid β-oxidation pathway in HepG2 cells. Amino Acids 48 (5):1297–307. doi: 10.1007/s00726-016-2182-7.
  • Longo, M., F. Zatterale, J. Naderi, L. Parrillo, P. Formisano, G. A. Raciti, F. Beguinot, and C. Miele. 2019. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. International Journal of Molecular Sciences 20 (9):2358. doi: 10.3390/ijms20092358.
  • Loo, R. L., Q. Chan, J. K. Nicholson, and E. Holmes. 2022. Balancing the equation: A natural history of trimethylamine and trimethylamine-N-oxide. Journal of Proteome Research 21 (3):560–89. doi: 10.1021/acs.jproteome.1c00851.
  • Loos, R. J. 2012. Genetic determinants of common obesity and their value in prediction. Best Practice & Research. Clinical Endocrinology & Metabolism 26 (2):211–26. doi: 10.1016/j.beem.2011.11.003.
  • Loos, R. J. F., C. M. Lindgren, S. Li, E. Wheeler, J. H. Zhao, I. Prokopenko, M. Inouye, R. M. Freathy, A. P. Attwood, J. S. Beckmann, et al. 2008. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nature Genetics 40 (6):768–75. doi: 10.1038/ng.140.
  • Loos, R. J., and G. S. Yeo. 2022. The genetics of obesity: From discovery to biology. Nature Reviews Genetics 23 (2):120–33. doi: 10.1038/s41576-021-00414-z.
  • López-Jaramillo, P., D. Gómez-Arbeláez, J. López-López, C. López-López, J. Martínez-Ortega, A. Gómez-Rodríguez, and S. Triana-Cubillos. 2014. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes. Hormone Molecular Biology and Clinical Investigation 18 (1):37–45. doi: 10.1515/hmbci-2013-0053.
  • Lorenzo, P. M., A. G. Izquierdo, G. Rodriguez-Carnero, A. Fernández-Pombo, A. Iglesias, M. C. Carreira, C. Tejera, D. Bellido, M. A. Martinez-Olmos, R. Leis, et al. 2022. Epigenetic effects of healthy foods and lifestyle habits from the Southern European Atlantic diet pattern: A narrative review. Advances in Nutrition (Bethesda, Md.) 13 (5):1725–47. doi: 10.1093/advances/nmac038.
  • Lotta, L. A., R. A. Scott, S. J. Sharp, S. Burgess, J. Luan, T. Tillin, A. F. Schmidt, F. Imamura, I. D. Stewart, J. R. B. Perry, et al. 2016. Genetic predisposition to an impaired metabolism of the branched-chain amino acids and risk of type 2 diabetes: A Mendelian randomisation analysis. PLoS Medicine 13 (11):e1002179. doi: 10.1371/journal.pmed.1002179.
  • Lovejoy, J., F. D. Newby, S. S. Gebhart, and M. DiGirolamo. 1992. Insulin resistance in obesity is associated with elevated basal lactate levels and diminished lactate appearance following intravenous glucose and insulin. Metabolism: clinical and Experimental 41 (1):22–7. doi: 10.1016/0026-0495(92)90185-D.
  • Lukito, W., S. G. Malik, I. S. Surono, and M. L. Wahlqvist. 2015. From “lactose intolerance” to “lactose nutrition. Asia Pacific Journal of Clinical Nutrition 24 (Suppl 1):S1–S8. doi: 10.6133/apjcn.2015.24.s1.01.
  • Lv, Q., X. F. Meng, F. F. He, S. Chen, H. Su, J. Xiong, P. Gao, X. Juan Tian, J. S. Liu, Z. Hua Zhu, et al. 2013. High serum uric acid and increased risk of type 2 diabetes: A systemic review and meta-analysis of prospective cohort studies. PLoS One. 8 (2):e56864. doi: 10.1371/journal.pone.0056864.
  • MacCaferri, S., E. Biagi, and P. Brigidi. 2011. Metagenomics: Key to human gut microbiota. Digestive Diseases (Basel, Switzerland) 29 (6):525–30. doi: 10.1159/000332966.
  • Mahajan, A., X. Sim, H. J. Ng, A. Manning, M. A. Rivas, H. M. Highland, A. E. Locke, N. Grarup, H. K. Im, P. Cingolani, et al. 2015. Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus. PLoS Genetics 11 (1):e1004876. doi: 10.1371/journal.pgen.1004876.
  • Mai, M., A. Tönjes, P. Kovacs, M. Stumvoll, G. M. Fiedler, and A. Benedikt Leichtle. 2013. Serum levels of acylcarnitines are altered in prediabetic conditions. PLoS One. 8 (12):e82459. doi: 10.1371/journal.pone.0082459.
  • Maltais-Payette, I., M.-M. Boulet, C. Prehn, J. Adamski, and A. Tchernof. 2018. Circulating glutamate concentration as a biomarker of visceral obesity and associated metabolic alterations. Nutrition & Metabolism 15 (1):78. doi: 10.1186/s12986-018-0316-5.
  • Mandracchia, F., E. Llauradó, L. Tarro, J. del Bas, R. Valls, A. Pedret, P. Radeva, L. Arola, R. Solà, and N. Boqué. 2019. Potential use of mobile phone applications for self-monitoring and increasing daily fruit and vegetable consumption: A systematized review. Nutrients 11 (3):686. doi: 10.3390/nu11030686.
  • Manning, A. K., M.-F. Hivert, R. A. Scott, J. L. Grimsby, N. Bouatia-Naji, H. Chen, D. Rybin, C.-T. Liu, L. F. Bielak, I. Prokopenko, et al. 2012. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nature Genetics 44 (6):659–69. doi: 10.1038/ng.2274.
  • Marti, A., I. Martínez, A. Ojeda‐rodríguez, and M. C. Azcona‐sanjulian. 2021. Higher lipopolysaccharide binding protein and chemerin concentrations were associated with metabolic syndrome features in pediatric subjects with abdominal obesity during a lifestyle intervention. Nutrients 13 (2):289. doi: 10.3390/nu13020289.
  • Martini, D., M. Tucci, J. Bradfield, A. Di Giorgio, M. Marino, C. Del Bo’, M. Porrini, and P. Riso. 2021. Principles of sustainable healthy diets in worldwide dietary guidelines: Efforts so far and future perspectives. Nutrients 13 (6):1827. doi: 10.3390/nu13061827.
  • Maruvada, P., J. W. Lampe, D. S. Wishart, D. Barupal, D. N. Chester, D. Dodd, Y. Djoumbou-Feunang, P. C. Dorrestein, L. O. Dragsted, J. Draper, et al. 2020. Perspective: Dietary biomarkers of intake and exposure-exploration with omics approaches. Advances in Nutrition (Bethesda, Md.) 11 (2):200–15. doi: 10.1093/advances/nmz075.
  • Matsumori, R., T. Miyazaki, K. Shimada, A. Kume, Y. Kitamura, K. Oshida, N. Yanagisawa, T. Kiyanagi, M. Hiki, K. Fukao, et al. 2013. High levels of very long-chain saturated fatty acid in erythrocytes correlates with atherogenic lipoprotein profiles in subjects with metabolic syndrome. Diabetes Research and Clinical Practice 99 (1):12–8. doi: 10.1016/J.DIABRES.2012.10.025.
  • Matthan, N. R., L. M. Ausman, H. Meng, H. Tighiouart, and A. H. Lichtenstein. 2016. Estimating the reliability of glycemic index values and potential sources of methodological and biological variability. The American Journal of Clinical Nutrition 104 (4):1004–13. doi: 10.3945/ajcn.116.137208.
  • Matthews, D. R., J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treache, and D. R. Turner. 1985. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (7):412–9. doi: 10.1007/BF00280883.
  • Mayorga-Ramos, A., C. Barba-Ostria, D. Simancas-Racines, and L. P. Guamán. 2022. Protective role of butyrate in obesity and diabetes: new insights. Frontiers in Nutrition 9:1067647. doi: 10.3389/fnut.2022.1067647.
  • McGarrah, R. W., J. P. Kelly, D. M. Craig, C. Haynes, R. C. Jessee, K. M. Huffman, W. E. Kraus, and S. H. Shah. 2017. A novel protein glycan-derived inflammation biomarker independently predicts cardiovascular disease and modifies the association of HDL subclasses with mortality. Clinical Chemistry 63 (1):288–96. doi: 10.1373/clinchem.2016.261636.
  • Meng, D., L. Liang, and X. Guo. 2019. Serum interleukin-10 level in patients with inflammatory bowel disease: A meta-analysis. European Journal of Inflammation 17 (January):205873921984340. doi: 10.1177/2058739219843405.
  • Meng, H., N. R. Matthan, L. M. Ausman, and A. H. Lichtenstein. 2017. Effect of prior meal macronutrient composition on postprandial glycemic responses and glycemic index and glycemic load value determinations. The American Journal of Clinical Nutrition 106 (5):1246–56. doi: 10.3945/ajcn.117.162727.
  • Meyer, K. A., and J. W. Shea. 2017. Dietary choline and betaine and risk of CVD: A systematic review and meta-analysis of prospective studies. Nutrients 9 (7):711. doi: 10.3390/nu9070711.
  • Mihalik, S. J., B. H. Goodpaster, D. E. Kelley, D. H. Chace, J. Vockley, F. G. Toledo, and J. P. Delany. 2010. Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity 18 (9):1695–700. doi: 10.1038/oby.2009.510.
  • Milajerdi, A., S. M. Mousavi, A. Sadeghi, A. Salari-Moghaddam, M. Parohan, B. Larijani, and A. Esmaillzadeh. 2020. The effect of probiotics on inflammatory biomarkers: A meta-analysis of randomized clinical trials. European Journal of Nutrition 59 (2):633–49. doi: 10.1007/S00394-019-01931-8.
  • Milne, G. L., E. S. Musiek, and J. D. Morrow. 2005. F2-isoprostanes as markers of oxidative stress in vivo: An overview. Biomarkers 10 (Suppl 1):S10–S23. doi: 10.1080/13547500500216546.
  • Minihane, A. M., S. Vinoy, W. R. Russell, A. Baka, H. M. Roche, K. M. Tuohy, J. L. Teeling, E. E. Blaak, M. Fenech, D. Vauzour, et al. 2015. Low-grade inflammation, diet composition and health: Current research evidence and its translation. British Journal of Nutrition 114 (7):999–1012. doi: 10.1017/S0007114515002093.
  • Mir, R., M. Bhat, J. Javid, C. Jha, A. Saxena, and S. Banu. 2018. Potential impact of COMT-Rs4680 G > A gene polymorphism in coronary artery disease. Journal of Cardiovascular Development and Disease 5 (3):38. doi: 10.3390/jcdd5030038.
  • Miyazaki, M., and J. M. Ntambi. 2003. Role of stearoyl-coenzyme a desaturase in lipid metabolism. Prostaglandins, Leukotrienes, and Essential Fatty Acids 68 (2):113–21. doi: 10.1016/S0952-3278(02)00261-2.
  • Mohammad, S., and C. Thiemermann. 2020. Role of metabolic endotoxemia in systemic inflammation and potential interventions. Frontiers in Immunology 11 (January):594150. doi: 10.3389/fimmu.2020.594150.
  • Moon, S., J. J. Tsay, H. Lampert, Z. I. Md Dom, A. D. Kostic, A. Smiles, and M. A. Niewczas. 2021. Circulating short and medium chain fatty acids are associated with normoalbuminuria in type 1 diabetes of long duration. Scientific Reports 11 (1): 8592. doi: 10.1038/s41598-021-87585-1.
  • Morrison, L., J. A. Laukkanen, K. Ronkainen, S. Kurl, J. Kauhanen, and A. T. Toriola. 2016. Inflammatory biomarker score and cancer: A population-based prospective cohort study. BMC Cancer 16 (1):80. doi: 10.1186/s12885-016-2115-6.
  • Morze, J., C. Wittenbecher, L. Schwingshackl, A. Danielewicz, A. Rynkiewicz, F. B. Hu, and M. Guasch-Ferre. 2022. Metabolomics and type 2 diabetes risk: an updated systematic review and meta-analysis of prospective cohort studies. Diabetes Care 45 (4):1013–24. doi: 10.2337/DC21-1705.
  • Moszak, M., M. Szulińska, and P. Bogdański. 2020. You are what you eat—the relationship between diet, microbiota, and metabolic disorders—A review. Nutrients. MDPI AG 12 (4):1096. doi: 10.3390/nu12041096.
  • Motamedi, A., M. Askari, H. Mozaffari, R. Homayounfrar, A. Nikparast, M. L. Ghazi, M. M. Nejad, and S. Alizadeh. 2022. Dietary inflammatory index in relation to type 2 diabetes: A meta-analysis. International Journal of Clinical Practice 2022 (February):9953115. doi: 10.1155/2022/9953115.
  • Mukherjee, M. S., C. Y. Han, S. Sukumaran, C. L. Delaney, and M. D. Miller. 2022. Effect of anti-inflammatory diets on inflammation markers in adult human populations: A systematic review of randomized controlled trials. Nutrition Reviews 81 (1):55–74. doi: 10.1093/nutrit/nuac045.
  • Mullins, V. A., W. Bresette, L. Johnstone, B. Hallmark, and F. H. Chilton. 2020. Genomics in personalized nutrition: can you “eat for your genes”? Nutrients 12 (10):3118. doi: 10.3390/nu12103118.
  • Murray, C. J. L., A. Y. Aravkin, P. Zheng, C. Abbafati, K. M. Abbas, M. Abbasi-Kangevari, F. Abd-Allah, A. Abdelalim, M. Abdollahi, I. Abdollahpour, et al. 2020. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: A systematic analysis for the global burden of disease study 2019. The Lancet 396 (10258):1223–49. doi: 10.1016/S0140-6736(20)30752-2.
  • Nagrani, R., R. Foraita, M. Wolters, S. De Henauw, S. Marild, D. Molnár, L. A. Moreno, P. Russo, M. Tornaritis, T. Veidebaum, et al. 2022. Longitudinal association of inflammatory markers with markers of glycaemia and insulin resistance in European Children. Diabetes/Metabolism Research and Reviews 38 (3):e3511. doi: 10.1002/DMRR.3511.
  • Nagy, R., T. S. Boutin, J. Marten, J. E. Huffman, S. M. Kerr, A. Campbell, L. Evenden, J. Gibson, C. Amador, D. M. Howard, et al. 2017. Exploration of haplotype research consortium imputation for genome-wide association studies in 20,032 generation scotland participants. Genome Medicine 9 (1):1. doi: 10.1186/s13073-017-0414-4.
  • Newgard, C. B. 2017. Metabolomics and metabolic diseases: Where do we stand? Cell Metabolism 25 (1):43–56. doi: 10.1016/j.cmet.2016.09.018.
  • Newman, J. C., and E. Verdin. 2014. β-Hydroxybutyrate: Much more than a metabolite. Diabetes Research and Clinical Practice 106 (2):173–81. doi: 10.1016/j.diabres.2014.08.009.
  • Ni, C., Q. Jia, G. Ding, X. Wu, and M. Yang. 2022. Low-glycemic index diets as an intervention in metabolic diseases: A systematic review and meta-analysis. Nutrients 14 (2):307. doi: 10.3390/nu14020307.
  • Niforou, A., V. Konstantinidou, and A. Naska. 2020. Genetic variants shaping inter-individual differences in response to dietary intakes—A narrative review of the case of vitamins. Frontiers in Nutrition 7 (December): 558598. doi: 10.3389/fnut.2020.558598.
  • Nutrition and Food Systems Division. 2016. Influencing food environments for healthy diets. Edited by Food and agriculture organization of the United Nations.
  • Olsen, J. V., and M. Mann. 2004. Improved peptide identification in proteomics by two consecutive stages of mass spectrometric fragmentation. Proceedings of the National Academy of Sciences of the United States of America 101 (37):13417–22. doi: 10.1073/pnas.0405549101.
  • Ordovas, J. M., L. R. Ferguson, E. S. Tai, and J. C. Mathers. 2018. Personalised Nutrition and Health. BMJ (Online) 361:bmj.k2173. doi: 10.1136/bmj.k2173.
  • Ouyang, W., and A. O’Garra. 2019. IL-10 family cytokines IL-10 and IL-22: From basic science to clinical translation. Immunity 50 (4):871–91. doi: 10.1016/J.IMMUNI.2019.03.020.
  • Palau-Rodriguez, M., S. Tulipani, M. Isabel Queipo-Ortuño, M. Urpi-Sarda, F. J. Tinahones, and C. Andres-Lacueva. 2015. Metabolomic insights into the intricate gut microbial-host interaction in the development of obesity and type 2 diabetes. Frontiers in Microbiology 6:1151. doi: 10.3389/fmicb.2015.01151.
  • Panduro, A., I. Rivera-Iñiguez, M. Sepulveda-Villegas, and S. Roman. 2017. Genes, emotions and gut microbiota: The next frontier for the gastroenterologist. World Journal of Gastroenterology 23 (17):3030–42. doi: 10.3748/wjg.v23.i17.3030.
  • Papakonstantinou, E., C. Oikonomou, G. Nychas, and G. D. Dimitriadis. 2022. Effects of diet, lifestyle, chrononutrition and alternative dietary interventions on postprandial glycemia and insulin resistance. Nutrients 14 (4):823. doi: 10.3390/nu14040823.
  • Pasanta, D., S. Chancharunee, M. Tungjai, H. J. Kim, and S. Kothan. 2019. Effects of obesity on the lipid and metabolite profiles of young adults by serum (1)H-NMR spectroscopy. PeerJ. 7:e7137. doi: 10.7717/peerj.7137.
  • Pausova, Z., C. Syme, M. Abrahamowicz, Y. Xiao, G. T. Leonard, M. Perron, L. Richer, S. Veillette, G. D. Smith, O. Seda, et al. 2009. A common variant of the FTO Gene is associated with not only increased adiposity but also elevated blood pressure in french Canadians. Circulation. Cardiovascular Genetics 2 (3):260–9. doi: 10.1161/CIRCGENETICS.109.857359.
  • Peña-Romero, A. C., D. Navas-Carrillo, F. Marín, and E. Orenes-Piñero. 2018. The future of nutrition: Nutrigenomics and nutrigenetics in obesity and cardiovascular diseases. Critical Reviews in Food Science and Nutrition 58 (17):3030–41. doi: 10.1080/10408398.2017.1349731.
  • Perla, F., M. Prelati, M. Lavorato, D. Visicchio, and C. Anania. 2017. The role of lipid and lipoprotein metabolism in non‐alcoholic fatty liver disease. Children 4 (6):46. doi: 10.3390/children4060046.
  • Picó, C., F. Serra, A. M. Rodríguez, J. Keijer, and A. Palou. 2019. Biomarkers of nutrition and health: New tools for new approaches. Nutrients. MDPI AG 11 (5):1092. doi: 10.3390/nu11051092.
  • Playdon, M. C., S. C. Moore, A. Derkach, J. Reedy, A. F. Subar, J. N. Sampson, D. Albanes, F. Gu, J. Kontto, C. Lassale, et al. 2017. Identifying biomarkers of dietary patterns by using metabolomics. The American Journal of Clinical Nutrition 105 (2):450–65. doi: 10.3945/ajcn.116.144501.
  • Portha, B., A. Fournier, M. D. A. Kioon, V. Mezger, and J. Movassat. 2014. Early environmental factors, alteration of epigenetic marks and metabolic disease susceptibility. Biochimie 97 (February):1–15. doi: 10.1016/j.biochi.2013.10.003.
  • Posma, J. M., I. Garcia-Perez, G. Frost, G. S. Aljuraiban, Q. Chan, L. Van Horn, M. Daviglus, J. Stamler, E. Holmes, P. Elliott, et al. 2020. Nutriome–metabolome relationships provide insights into dietary intake and metabolism. Nature Food 1 (7):426–36. doi: 10.1038/s43016-020-0093-y.
  • Qin, J., Y. Li, Z. Cai, S. Li, J. Zhu, F. Zhang, S. Liang, W. Zhang, Y. Guan, D. Shen, et al. 2012. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490 (7418):55–60. doi: 10.1038/nature11450.
  • Qiu, S., X. Cai, J. Liu, B. Yang, M. Zügel, J. M. Steinacker, Z. Sun, and U. Schumann. 2019. Association between circulating cell adhesion molecules and risk of type 2 diabetes: A meta-analysis. Atherosclerosis 287 (August):147–54. doi: 10.1016/J.ATHEROSCLEROSIS.2019.06.908.
  • Ramos-Lopez, O., I. Milton-Laskibar, and J. A. Martínez. 2021. Precision nutrition based on phenotypical traits and the (epi)genotype: Nutrigenetic and nutrigenomic approaches for obesity care. Current Opinion in Clinical Nutrition and Metabolic Care 24 (4):315–25. doi: 10.1097/MCO.0000000000000754.
  • Rawat, A., G. Misra, M. Saxena, S. Tripathi, D. Dubey, S. Saxena, A. Aggarwal, V. Gupta, M. Y. Khan, and A. Prakash. 2019. 1H NMR based serum metabolic profiling reveals differentiating biomarkers in patients with diabetes and diabetes-related complication. Diabetes & Metabolic Syndrome 13 (1):290–8. doi: 10.1016/j.dsx.2018.09.009.
  • Reuter, S. E., and A. M. Evans. 2012. Carnitine and acylcarnitines. Clinical Pharmacokinetics 51 (9):553–72. doi: 10.1007/BF03261931.
  • Ridker, P. M., J. E. Buring, N. R. Cook, and N. Rifai. 2003. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-Year follow-up of 14 719 initially healthy American women. Circulation 107 (3):391–7. doi: 10.1161/01.CIR.0000055014.62083.05.
  • Roberts, L. D., A. Koulman, and J. L. Griffin. 2014. Towards metabolic biomarkers of insulin resistance and type 2 diabetes: Progress from the metabolome. The Lancet Diabetes and Endocrinology. Lancet Publishing Group 2 (1):65–75. doi: 10.1016/S2213-8587(13)70143-8.
  • Robinette, S. L., E. Holmes, J. K. Nicholson, and M. E. Dumas. 2012. Genetic determinants of metabolism in health and disease: From biochemical genetics to genome-wide associations. Genome Medicine 4 (4):30. doi: 10.1186/gm329.
  • Rossi, A., M. Ruoppolo, P. Formisano, G. Villani, L. Albano, G. Gallo, D. Crisci, A. Moccia, G. Parenti, P. Strisciuglio, et al. 2018. Insulin-resistance in glycogen storage disease type Ia: Linking carbohydrates and mitochondria? Journal of Inherited Metabolic Disease 41 (6):985–95. doi: 10.1007/s10545-018-0149-4.
  • Rowland, I., G. Gibson, A. Heinken, K. Scott, J. Swann, I. Thiele, and K. Tuohy. 2018. Gut Microbiota functions: Metabolism of nutrients and other food components. European Journal of Nutrition 57 (1):1–24. doi: 10.1007/s00394-017-1445-8.
  • Sacks, G., J. Kwon, and K. Backholer. 2021. Do taxes on unhealthy foods and beverages influence food purchases? Current Nutrition Reports 10 (3):179–87. doi: 10.1007/s13668-021-00358-0.
  • Sacks, F. M., A. H. Lichtenstein, J. H. Wu, L. J. Appel, M. A. Creager, P. M. Kris-Etherton, M. Miller, E. B. Rimm, L. L. Rudel, J. G. Robinson, et al. 2017. Dietary fats and cardiovascular disease: A presidential advisory from the American Heart Association. Circulation 136 (3):e1–e23. doi: 10.1161/CIR.0000000000000510.
  • Saito, N., T. Saito, T. Yamazaki, Y. Fujimine, and T. Ihara. 2017. Establishment of an analytical method for accurate purity evaluations of acylcarnitines by using quantitative 1H NMR spectroscopy. Accreditation and Quality Assurance 22 (4):171–8. doi: 10.1007/s00769-017-1263-y.
  • Schooneman, M. G., N. Achterkamp, C. A. Argmann, M. R. Soeters, and S. M. Houten. 2014. Plasma acylcarnitines inadequately reflect tissue acylcarnitine metabolism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1841 (7):987–94. doi: 10.1016/j.bbalip.2014.04.001.
  • Schram, M. T., S. J. S. Sep, C. J. van der Kallen, P. C. Dagnelie, A. Koster, N. Schaper, R. M. A. Henry, and C. D. A. Stehouwer. 2014. The Maastricht study: An extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities. European Journal of Epidemiology 29 (6):439–51. doi: 10.1007/s10654-014-9889-0.
  • Schwartz, B. 2014. New criteria for supplementation of selected micronutrients in the era of nutrigenetics and nutrigenomics. International Journal of Food Sciences and Nutrition 65 (5):529–38. doi: 10.3109/09637486.2014.898258.
  • Schwingshackl, L., and G. Hoffmann. 2014. Mediterranean dietary pattern, inflammation and endothelial function: A systematic review and meta-analysis of intervention trials. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 24 (9):929–39. doi: 10.1016/J.NUMECD.2014.03.003.
  • Sempionatto, J. R., V. R.-V. Montiel, E. Vargas, H. Teymourian, and J. Wang. 2021. Wearable and mobile sensors for personalized nutrition. ACS Sensors 6 (5):1745–60. doi: 10.1021/acssensors.1c00553.
  • Shabana, S. U. Shahid, and S. Hasnain. 2018. Use of a gene score of multiple low-modest effect size variants can predict the risk of obesity better than the individual SNPs. Lipids in Health and Disease 17 (1):155. doi: 10.1186/s12944-018-0806-5.
  • Shearer, J., G. Duggan, A. Weljie, D. S. Hittel, D. H. Wasserman, and H. J. Vogel. 2008. Metabolomic profiling of dietary-induced insulin resistance in the high fat-fed C57BL/6J mouse. Diabetes, Obesity & Metabolism 10 (10):950–8. doi: 10.1111/j.1463-1326.2007.00837.x.
  • Shimazu, T., M. D. Hirschey, J. Newman, W. He, K. Shirakawa, N. Le Moan, C. A. Grueter, H. Lim, L. R. Saunders, R. D. Stevens, et al. 2013. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science (New York, N.Y.) 339 (6116):211–4. doi: 10.1126/science.1227166.
  • Shin, S. Y., E. B. Fauman, A. K. Petersen, J. Krumsiek, R. Santos, J. Huang, M. Arnold, I. Erte, V. Forgetta, T. P. Yang, et al. 2014. An atlas of genetic influences on human blood metabolites. Nature Genetics 46 (6):543–50. doi: 10.1038/ng.2982.
  • Shivappa, N., J. R. Hebert, M. Kivimaki, and T. Akbaraly. 2017. Alternative Healthy Eating Index 2010, dietary inflammatory index and risk of mortality: Results from the Whitehall II cohort study and meta-analysis of previous dietary inflammatory index and mortality studies. The British Journal of Nutrition 118 (3):210–21. doi: 10.1017/S0007114517001908.
  • Simó, C., and V. García-Cañas. 2020. Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development. Food & Function 11 (8):6745–76. doi: 10.1039/D0FO01237H.
  • Siomkajło, M., and J. Daroszewski. 2019. Branched chain amino acids: Passive biomarkers or the key to the pathogenesis of cardiometabolic diseases? Advances in Clinical and Experimental Medicine 28 (9):1263–9. doi: 10.17219/acem/104542.
  • Smith, J. G., and R. E. Gerszten. 2017. Emerging affinity-based proteomic technologies for large-scale plasma profiling in cardiovascular disease. Circulation 135 (17):1651–64. doi: 10.1161/CIRCULATIONAHA.116.025446.
  • Soldatovic, I., R. Vukovic, D. Culafic, M. Gajic, and V. Dimitrijevic-Sreckovic. 2016. SiMS Score: Simple method for quantifying metabolic syndrome. Plos ONE 11 (1):e0146143. doi: 10.1371/journal.pone.0146143.
  • Sookoian, S., and C. J. Pirola. 2012. Alanine and aspartate aminotransferase and glutamine-cycling pathway: Their roles in pathogenesis of metabolic syndrome. World Journal of Gastroenterology 18 (29):3775–81. doi: 10.3748/wjg.v18.i29.3775.
  • Southward, K., K. Rutherfurd-Markwick, C. Badenhorst, and A. Ali. 2018. The role of genetics in moderating the inter-individual differences in the ergogenicity of caffeine. Nutrients 10 (10):1352. doi: 10.3390/nu10101352.
  • Speliotes, E. K., C. J. Willer, S. I. Berndt, K. L. Monda, G. Thorleifsson, A. U. Jackson, H. Lango Allen, C. M. Lindgren, J. Luan, R. Mägi, et al. 2010. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nature Genetics 42 (11):937–48. doi: 10.1038/ng.686.
  • Sprague, A. H., and R. A. Khalil. 2009. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochemical Pharmacology 78 (6):539–52. doi: 10.1016/j.bcp.2009.04.029.
  • Stradomska, T. J., M. Syczewska, E. Jamroz, A. Pleskaczyńska, P. Kruczek, E. Ciara, and A. Tylki-Szymanska. 2020. Serum very long-chain fatty acids (VLCFA) levels as predictive biomarkers of diseases severity and probability of survival in peroxisomal disorders. PloS One 15 (9):e0238796. doi: 10.1371/JOURNAL.PONE.0238796.
  • Suárez, M., N. Boqué, J. M. Del Bas, J. Mayneris-Perxachs, L. Arola, and A. Caimari. 2017. Mediterranean diet and multi-ingredient-based interventions for the management of non-alcoholic fatty liver disease. Nutrients 9 (10):1052. doi: 10.3390/nu9101052.
  • Suleiman, J., M. Mohamed, and A. Bakar. 2020. A systematic review on different models of inducing obesity in animals: Advantages and limitations. Journal of Advanced Veterinary and Animal Research 7 (1):103–14. doi: 10.5455/javar.2020.g399.
  • Sun, B. B., J. C. Maranville, J. E. Peters, D. Stacey, J. R. Staley, J. Blackshaw, S. Burgess, T. Jiang, E. Paige, P. Surendran, et al. 2018. Genomic atlas of the human plasma proteome. Nature 558 (7708):73–9. doi: 10.1038/s41586-018-0175-2.
  • Surendran, A., N. Atefi, H. Zhang, M. Aliani, and A. Ravandi. 2021. Defining acute coronary syndrome through metabolomics. Metabolites 11 (10):685. doi: 10.3390/metabo11100685.
  • Sutton, A., A. Imbert, A. Igoudjil, V. Descatoire, S. Cazanave, D. Pessayre, and F. Degoul. 2005. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and MRNA stability. Pharmacogenetics and Genomics 15 (5):311–9. doi: 10.1097/01213011-200505000-00006.
  • ‘t Hart, L. M., N. Vogelzangs, D. O. Mook-Kanamori, A. Brahimaj, J. Nano, A. A. W. A. van der Heijden, K. Willems van Dijk, R. C. Slieker, E. W. Steyerberg, M. A. Ikram, et al. 2018. Blood metabolomic measures associate with present and future glycemic control in type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism 103 (12):4569–79. doi: 10.1210/jc.2018-01165.
  • Tabassum, R., J. T. Rämö, P. Ripatti, J. T. Koskela, M. Kurki, J. Karjalainen, P. Palta, S. Hassan, J. Nunez-Fontarnau, T. T. J. Kiiskinen, et al. 2019. Genetic architecture of human plasma lipidome and its link to cardiovascular disease. Nature Communications 10 (1):4329. doi: 10.1038/s41467-019-11954-8.
  • Tebani, A., and S. Bekri. 2019. Paving the way to precision nutrition through metabolomics. Frontiers in Nutrition 6:41. doi: 10.3389/fnut.2019.00041.
  • The Lancet. 2009. What is health? The ability to adapt. Lancet (London, England) 373 (9666):781. doi: 10.1016/S0140-6736(09)60456-6.
  • Thorleifsson, G., G. B. Walters, D. F. Gudbjartsson, V. Steinthorsdottir, P. Sulem, A. Helgadottir, U. Styrkarsdottir, S. Gretarsdottir, S. Thorlacius, I. Jonsdottir, et al. 2009. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nature Genetics 41 (1):18–24. doi: 10.1038/ng.274.
  • Tin, A., P. Balakrishnan, T. H. Beaty, E. Boerwinkle, R. C. Hoogeveen, J. H. Young, and W. H. Kao. 2016. GCKR and PPP1R3B identified as genome-wide significant loci for plasma lactate: The atherosclerosis risk in communities (ARIC) study. Diabetic Medicine: A Journal of the British Diabetic Association 33 (7):968–75. doi: 10.1111/dme.12971.
  • Tintle, N. L., J. V. Pottala, S. Lacey, V. Ramachandran, J. Westra, A. Rogers, J. Clark, B. Olthoff, M. Larson, W. Harris, et al. 2015. A genome-wide association study of saturated, mono- and polyunsaturated red blood cell fatty acids in the framingham heart offspring study. Prostaglandins, Leukotrienes, and Essential Fatty Acids 94 (March):65–72. doi: 10.1016/j.plefa.2014.11.007.
  • Tulipani, S., M. Palau-Rodriguez, A. Minarro Alonso, F. Cardona, A. Marco-Ramell, B. Zonja, M. Lopez de Alda, A. Munoz-Garach, A. Sanchez-Pla, F. J. Tinahones, et al. 2016. Biomarkers of morbid obesity and prediabetes by metabolomic profiling of human discordant phenotypes. Clinica Chimica Acta; International Journal of Clinical Chemistry 463 (December):53–61. doi: 10.1016/j.cca.2016.10.005.
  • Turck, D., J. Castenmiller, S. De Henauw, K. I. Hirsch-Ernst, J. Kearney, H. K. Knutsen, A. Maciuk, I. Mangelsdorf, H. J. McArdle, A. Naska, et al. 2018. Guidance on the scientific requirements for health claims related to muscle function and physical performance: (Revision 1). EFSA Journal 16 (10): 5434. doi: 10.2903/j.efsa.2018.5434.
  • Turck, D., J. L. Bresson, B. Burlingame, T. Dean, S. Fairweather-Tait, M. Heinonen, K. I. Hirsch-Ernst, I. Mangelsdorf, H. J. McArdle, A. Naska, et al. 2018. Guidance for the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health: (revision 1). EFSA Journal 16 (1):. 136 10.2903/J.EFSA.2018.5136.
  • Udler, M. S., M. I. McCarthy, J. C. Florez, and A. Mahajan. 2019. Genetic risk scores for diabetes diagnosis and precision medicine. Endocrine Reviews 40 (6):1500–20. doi: 10.1210/er.2019-00088.
  • Ulaszewska, M., N. Vázquez-Manjarrez, M. Garcia-Aloy, R. Llorach, F. Mattivi, L. O. Dragsted, G. Praticò, and C. Manach. 2018. Food intake biomarkers for apple, pear, and stone fruit. Genes & Nutrition 13 (1):29. doi: 10.1186/s12263-018-0620-8.
  • Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus Abbreviated Report of a WHO Consultation. 2011.
  • van der Aa, M. P., C. A. J. Knibbe, A. D. Boer, and M. M. J. van der Vorst. 2017. Definition of insulin resistance affects prevalence rate in pediatric patients: A systematic review and call for consensus. Journal of Pediatric Endocrinology & Metabolism: JPEM 30 (2):123–31. doi: 10.1515/jpem-2016-0242.
  • van der Hoek, M. D., A. G. Nieuwenhuizen, O. Kuda, P. Bos, V. Paluchová, L. Verschuren, A. M. van den Hoek, R. Kleemann, N. J. G. M. Veeger, F. R. van der Leij, et al. 2020. Intramuscular short-chain acylcarnitines in elderly people are decreased in (pre-)frail females, but not in males. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 34 (9):11658–71. doi: 10.1096/fj.202000493R.
  • van Heel, D. A., L. Franke, K. A. Hunt, R. Gwilliam, A. Zhernakova, M. Inouye, M. C. Wapenaar, M. C. N. M. Barnardo, G. Bethel, G. K. T. Holmes, et al. 2007. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nature Genetics 39 (7):827–9. doi: 10.1038/ng2058.
  • van Meurs, J. B. J., G. Pare, S. M. Schwartz, A. Hazra, T. Tanaka, S. H. Vermeulen, I. Cotlarciuc, X. Yuan, A. Mälarstig, S. Bandinelli, et al. 2013. Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease. The American Journal of Clinical Nutrition 98 (3):668–76. doi: 10.3945/ajcn.112.044545.
  • van Ommen, B., J. Keijer, S. G. Heil, and J. Kaput. 2009. Challenging homeostasis to define biomarkers for nutrition related health. Molecular Nutrition & Food Research 53 (7):795–804. doi: 10.1002/mnfr.200800390.
  • van Ommen, B., J. Keijer, R. Kleemann, R. Elliott, C. A. Drevon, H. McArdle, M. Gibney, and M. Müller. 2008. The challenges for molecular nutrition research 2: Quantification of the nutritional phenotype. Genes & Nutrition 3 (2):51–9. doi: 10.1007/s12263-008-0084-3.
  • van Ommen, B., J. van der Greef, J. M. Ordovas, and H. Daniel. 2014. Phenotypic flexibility as key factor in the human nutrition and health relationship. Genes & Nutrition 9 (5):423. doi: 10.1007/s12263-014-0423-5.
  • Van’t Erve, T. J. 2018. Strategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F2α. Redox Biology 17 (July):284–96. doi: 10.1016/j.redox.2018.05.003.
  • Vashist, S. K. 2021. Trends in multiplex immunoassays for in vitro diagnostics and point-of-care testing. Diagnostics 11 (9):1630. doi: 10.3390/diagnostics11091630.
  • Vega-López, S., L. M. Ausman, J. L. Griffith, and A. H. Lichtenstein. 2007. Interindividual variability and intra-individual reproducibility of glycemic index values for commercial white bread. Diabetes Care 30 (6):1412–7. doi: 10.2337/dc06-1598.
  • Wang, Y., Y. Tang, Y. Ji, W. Xu, N. Ullah, H. Yu, Y. Wu, and L. Xie. 2021. Association between FADS1 Rs174547 and levels of long-chain PUFA: A meta-analysis. The British Journal of Nutrition 126 (8):1121–9. doi: 10.1017/S0007114520005103.
  • Wang, Z., W. H. W. Tang, T. O’Connell, E. Garcia, E. J. Jeyarajah, X. S. Li, X. Jia, T. L. Weeks, and S. L. Hazen. 2022. Circulating trimethylamine N-oxide levels following fish or seafood consumption. European Journal of Nutrition 61 (5):2357–64. doi: 10.1007/s00394-022-02803-4.
  • Wessel, J., A. Y. Chu, S. M. Willems, S. Wang, H. Yaghootkar, J. A. Brody, M. Dauriz, M.-F. Hivert, S. Raghavan, L. Lipovich, et al. 2015. Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. Nature Communications 6 (January):5897. doi: 10.1038/ncomms6897.
  • Weverling-Rijnsburger, A. W., I. J. Jonkers, E. Van Exel, J. Gussekloo, and R. G. Westendorp. 2003. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Archives of Internal Medicine 163 (13):1549–54. doi: 10.1001/archinte.163.13.1549.
  • Willer, C. J., E. K. Speliotes, R. J. F. Loos, S. Li, C. M. Lindgren, I. M. Heid, S. I. Berndt, A. L. Elliott, A. U. Jackson, C. Lamina, et al. 2009. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nature Genetics 41 (1):25. doi: 10.1038/NG.287.
  • Willis, S. A., S. J. Bawden, S. Malaikah, J. A. Sargeant, D. J. Stensel, G. P. Aithal, and J. A. King. 2021. The role of hepatic lipid composition in obesity-related metabolic disease. Liver International: Official Journal of the International Association for the Study of the Liver 41 (12):2819–35. doi: 10.1111/LIV.15059.
  • Wu, H., and C. M. Ballantyne. 2020. Metabolic inflammation and insulin resistance in obesity. Circulation Research 126 (11):1549–64. doi: 10.1161/CIRCRESAHA.119.315896.
  • Wu, J. H. Y., R. N. Lemaitre, A. Manichaikul, W. Guan, T. Tanaka, M. Foy, E. K. Kabagambe, L. Djousse, D. Siscovick, A. M. Fretts, et al. 2013. Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: Results from the cohorts for heart and aging research in genomic epidemiology (CHARGE) Consortiu. Circulation. Cardiovascular Genetics 6 (2):171–83. doi: 10.1161/CIRCGENETICS.112.964619.
  • Würtz, P., M. Tiainen, V.-P. Mäkinen, A. J. Kangas, P. Soininen, J. Saltevo, S. Keinänen-Kiukaanniemi, P. Mäntyselkä, T. Lehtimäki, M. Laakso, et al. 2012. Circulating metabolite predictors of glycemia in middle-aged men and women. Diabetes Care 35 (8):1749–56. doi: 10.2337/dc11-1838.
  • Xu, B., J. Fu, Y. Qiao, J. Cao, E. C. Deehan, Z. Li, M. Jin, X. Wang, and Y. Wang. 2021. Higher intake of microbiota-accessible carbohydrates and improved cardiometabolic risk factors: A meta-analysis and umbrella review of dietary management in patients with type 2 diabetes. The American Journal of Clinical Nutrition 113 (6):1515–30. doi: 10.1093/AJCN/NQAA435.
  • Yao, M. E., P. D. Liao, X. J. Zhao, and L. Wang. 2020. Trimethylamine-N-oxide has prognostic value in coronary heart disease: A meta-analysis and dose-response analysis. BMC Cardiovascular Disorders 20 (1):7. doi: 10.1186/s12872-019-01310-5.
  • Yin, X., L. S. Chan, D. Bose, A. U. Jackson, P. VandeHaar, A. E. Locke, C. Fuchsberger, H. M. Stringham, R. Welch, K. Yu, et al. 2022. Genome-wide association studies of metabolites in finnish men identify disease-relevant loci. Nature Communications 13 (1):1644. doi: 10.1038/s41467-022-29143-5.
  • Zeng, Y., M. Guo, X. Fang, F. Teng, X. Tan, X. Li, M. Wang, Y. Long, and Y. Xu. 2021. Gut Microbiota-derived trimethylamine N-oxide and kidney function: A systematic review and meta-analysis. Advances in Nutrition (Bethesda, Md.) 12 (4):1286–304. doi: 10.1093/advances/nmab010.
  • Zhang, S., P. Wu, Y. Tian, B. Liu, L. Huang, Z. Liu, N. Lin, N. Xu, Y. Ruan, Z. Zhang, et al. 2021. Gut Microbiota serves a predictable outcome of short-term low-carbohydrate diet (LCD) intervention for patients with obesity. Microbiology Spectrum 9 (2):e0022321. doi: 10.1128/Spectrum.00223-21.
  • Zhang, X., C. Zhang, L. Chen, X. Han, and L. Ji. 2014. Human serum acylcarnitine profiles in different glucose tolerance states. Diabetes Research and Clinical Practice 104 (3):376–82. doi: 10.1016/j.diabres.2014.04.013.
  • Zhao, X., X. Gang, Y. Liu, C. Sun, Q. Han, and G. Wang. 2016. Using metabolomic profiles as biomarkers for insulin resistance in childhood obesity: A systematic review. Journal of Diabetes Research 2016:1–12. doi: 10.1155/2016/8160545.
  • Zock, P. L., W. A. M. Blom, J. A. Nettleton, and G. Hornstra. 2016. Progressing insights into the role of dietary fats in the prevention of cardiovascular disease. Current Cardiology Reports 18 (11): 111. doi: 10.1007/s11886-016-0793-y.